These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2036476)

  • 41. [Concentration of anti-brain antibodies in the blood of patients with diffuse toxic goiter and thyrotoxic encephalopathy].
    Oleĭnik VA; Malyzhev VA
    Probl Endokrinol (Mosk); 1986; 32(2):6-9. PubMed ID: 3754967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: markers of vulnerability or disease?
    Zorrilla EP; Cannon TD; Gur RE; Kessler J
    Biol Psychiatry; 1996 Nov; 40(9):825-33. PubMed ID: 8896768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Demonstration of nuclear and cytoplasmic fluorescence in brain tissues of schizophrenic and nonschizophrenic patients.
    Boehme DH; Cottrell JC; Dohan FC; Hillegass LM
    Biol Psychiatry; 1974 Feb; 8(1):89-94. PubMed ID: 4205639
    [No Abstract]   [Full Text] [Related]  

  • 44. Determination of anti-neutrophil cytoplasm antibodies (ANCA) specificity by immunofluorescence on chronic myelocytic leukemia cells.
    Chevailler A; Noel LH; Renier G; Gardembas-Pain M; Subra JF; Nusbaum P; Hurez D; Lesavre P
    J Immunol Methods; 1992 Feb; 147(1):101-9. PubMed ID: 1311734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antineural antibodies in patients with systemic lupus erythematosus].
    Schmidt RE; Ryan PF; Hughes GR; Stroehmann I
    Med Welt; 1981 Aug; 32(32-33):1216-8. PubMed ID: 7024709
    [No Abstract]   [Full Text] [Related]  

  • 46. [Changes of the level of serum antibodies to neuroantigens in patients with schizophrenia during the treatment].
    Kliushnik TP; Siriachenko TM; Sarmanova ZV; Otman IN; Dupin AM; Sokolov RE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(8):61-4. PubMed ID: 18833110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lamin B autoantibodies in sera of certain patients with systemic lupus erythematosus.
    Reeves WH; Chaudhary N; Salerno A; Blobel G
    J Exp Med; 1987 Mar; 165(3):750-62. PubMed ID: 3546581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients.
    Chengappa KN; Carpenter AB; Keshavan MS; Yang ZW; Kelly RH; Rabin BS; Ganguli R
    Biol Psychiatry; 1991 Oct; 30(7):731-5. PubMed ID: 1683585
    [No Abstract]   [Full Text] [Related]  

  • 49. Significance of an aging-linked neuron binding gamma globulin fraction of human sera.
    Ingram CR; Phegan KJ; Blumenthal HT
    J Gerontol; 1974 Jan; 29(1):20-7. PubMed ID: 4129288
    [No Abstract]   [Full Text] [Related]  

  • 50. [Reaction of anticerebral antibodies in the sera of patients with neuro-physic disorders to mitochondria and other fractions of brain tissue extract].
    Kuznetsova NI; Zykov IuV; Sorokina IN
    Biull Eksp Biol Med; 1966 Sep; 62(9):47-50. PubMed ID: 6012421
    [No Abstract]   [Full Text] [Related]  

  • 51. Myosin autoantibodies detected by immunofluorescence.
    Fairfax AJ; Gröschel-Stewart U
    Clin Exp Immunol; 1977 Apr; 28(1):27-34. PubMed ID: 324677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Brain antibodies in schizophrenia].
    Henneberg A; Ruffert S; Horter S; Kornhuber HH
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):583-6. PubMed ID: 7856265
    [No Abstract]   [Full Text] [Related]  

  • 53. A conformational epitope which detects autoantibodies from schizophrenic patients.
    Deckmann M; Mamillapalli R; Schechtman L; Shinitzky M
    Clin Chim Acta; 2002 Aug; 322(1-2):91-8. PubMed ID: 12104086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aspects of humoral and cellular immunity in schizophrenia.
    Vartanian ME; Kolyaskina GI; Lozovsky DV; Burbaeva GS; Ignatov SA
    Birth Defects Orig Artic Ser; 1978; 14(5):339-64. PubMed ID: 80239
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparative evaluation of unfixed and fixed human neutrophils for determination of antineutrophil cytoplasmic antibodies by indirect immunofluorescence.
    Yang P
    J Clin Pathol; 1997 Aug; 50(8):677-80. PubMed ID: 9301553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain-reactive antibodies in serum of old mice demonstrated by immunofluorescence.
    Threatt J; Nandy K; Fritz R
    J Gerontol; 1971 Jul; 26(3):316-23. PubMed ID: 4937292
    [No Abstract]   [Full Text] [Related]  

  • 57. Autoantibodies to fibroblasts in scleroderma.
    Brentnall TJ; Kenneally D; Barnett AJ; de Aizpurua HJ; Lolait SJ; Ashcroft R; Toh BH
    J Clin Lab Immunol; 1982 May; 8(1):9-12. PubMed ID: 7047748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluorescent antibody studies of immunoglobulin binding by brain tissues. Demonstration of cytoplasmic fluorescence by direct and indirect testing in schizophrenic and nonschizophrenic subjects.
    Boehme DH; Cottrell JC; Dohan FC; Hillegass LM
    Arch Gen Psychiatry; 1973 Feb; 28(2):202-7. PubMed ID: 4119296
    [No Abstract]   [Full Text] [Related]  

  • 59. Shift of attention in schizophrenics, siblings of schizophrenics, and depressed patients.
    Spring BJ
    J Nerv Ment Dis; 1980 Mar; 168(3):133-40. PubMed ID: 7354314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myelin basic protein antibodies in catatonic schizophrenia.
    Rimón R; Ahokas A; Ruutiainen J; Halonen P
    J Clin Psychiatry; 1986 Jan; 47(1):26-8. PubMed ID: 2416737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.